[HTML][HTML] Factors influencing vitamin D status

WG Tsiaras, MA Weinstock - Acta Dermato Venereologica, 2011 - vitamindwiki.com
The steroid hormone vitamin D is required for normal calcium and phosphorus metabolism
and is thus an important contributor to musculoskeletal health. Recent data have linked low …

Vitamin D and the anti-viral state

JA Beard, A Bearden, R Striker - Journal of Clinical Virology, 2011 - Elsevier
Vitamin D has long been recognized as essential to the skeletal system. Newer evidence
suggests that it also plays a major role regulating the immune system, perhaps including …

Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with …

GA McComsey, D Kitch, ES Daar… - Journal of Infectious …, 2011 - academic.oup.com
Abstract (See the editorial commentary by Yin and Overton, on pages 1705-7.) Background.
Long-term effects of abacavir (ABC)–lamivudine (3TC), compared with tenofovir (TDF) …

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

TT Brown, RB Qaqish - Aids, 2006 - journals.lww.com
Methods: We conducted a meta-analytical review of cross-sectional studies published in
English to determine the pooled odds ratios (OR) of reduced BMD and osteoporosis in the …

Bone disease in HIV infection: a practical review and recommendations for HIV care providers

GA McComsey, P Tebas, E Shane… - Clinical infectious …, 2010 - academic.oup.com
Low bone mineral density (BMD) is prevalent in human immunodeficiency virus (HIV)-
infected subjects. Initiation of antiretroviral therapy is associated with a 2%–6% decrease in …

Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen

TT Brown, GA McComsey, MS King… - JAIDS Journal of …, 2009 - journals.lww.com
Background: Decreased bone mineral density (BMD) has been described in HIV-infected
patients initiating antiretroviral therapy (ART), but the contributions of ART and immunologic …

Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence …

CN Dao, P Patel, ET Overton, F Rhame… - Clinical Infectious …, 2011 - academic.oup.com
Abstract (See the editorial commentary by Yin and Stein, on pages 406-408.) Background.
We explored serum 25-hydroxyvitamin D (25 [OH] D) levels and associated factors for …

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected …

C Duvivier, S Kolta, L Assoumou, J Ghosn… - Aids, 2009 - journals.lww.com
Objective: To evaluate the change in bone mineral density (BMD) at specific sites in patients
initiating antiretroviral therapy in a substudy of the ANRS 121 trial. Methods: Antiretroviral …

Metabolic profiling of major vitamin D metabolites using Diels–Alder derivatization and ultra-performance liquid chromatography–tandem mass spectrometry

PA Aronov, LM Hall, K Dettmer, CB Stephensen… - Analytical and …, 2008 - Springer
Biologically active forms of vitamin D are important analytical targets in both research and
clinical practice. The current technology is such that each of the vitamin D metabolites is …

High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients

NJ Mueller, CA Fux, B Ledergerber, L Elzi, P Schmid… - Aids, 2010 - journals.lww.com
Objectives: To evaluate the prevalence of 25-hydroxyvitamin D [25 (OH) D] deficiency in HIV-
positive patients, a population at risk for osteoporosis. Design: Retrospective assessment of …